The Ultimate Guide to AOD9604: Everything You Need to Succeed with High-Purity Lipolytic Peptides

02/27/2026 | Bio Bulk Peptides |

Technical Specifications

  • Molecular Formula: C78H123N23O23S2
  • Molecular Weight: 1815.1 g/mol
  • Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
  • CAS Number: 221231-10-3
  • PubChem CID: 16131447
  • Physical State: Lyophilized white powder
  • Purity: >99% (HPLC verified)
  • Solubility: Soluble in water or bacteriostatic water

Overview of AOD9604

AOD9604 (Advanced Obesity Drug 9604) is a synthetic analog of the human growth hormone (hGH). Specifically, it is a modified C-terminal fragment consisting of the last 16 amino acids (176–191) of the 191-amino acid hGH polypeptide, with an additional tyrosine residue at the N-terminal end to stabilize the molecule.

Historically, this peptide was developed to isolate the specific lipolytic (fat-burning) properties of growth hormone without the concomitant diabetogenic (blood sugar-altering) or mitogenic (growth-promoting) effects associated with the full-length hormone. In laboratory settings, AOD9604 is utilized to investigate metabolic pathways, lipid oxidation, and potential regenerative properties in connective tissues. For researchers, obtaining laboratory grade material is paramount to ensuring that experimental observations are the result of the peptide itself rather than contaminants or degradation products.

Mechanism of Action: Lipolysis and Lipogenesis

The primary mechanism of AOD9604 centers on its interaction with lipid metabolism. Unlike full-sequence hGH, which interacts with the growth hormone receptor (GHR) to stimulate the production of insulin-like growth factor 1 (IGF-1), AOD9604 appears to function through a pathway independent of hGH-induced systemic growth.

Activation of Beta-3 Adrenergic Receptors

Research suggests that AOD9604 exerts its effects by mimicking the way natural growth hormone regulates fat metabolism. It has been observed to stimulate lipolysis, the breakdown of lipids and the release of fatty acids from adipose tissue, primarily by targeting beta-3 adrenergic receptors. These receptors are highly expressed in adipose tissue and play a critical role in thermogenesis and lipid mobilization.

Inhibition of Lipogenesis

Beyond the promotion of fat breakdown, AOD9604 has been investigated for its ability to inhibit lipogenesis. This process involves the transformation of non-fat food materials (such as carbohydrates) into fat within the body. By potentially blocking the pathways that lead to the formation of new fat cells, the peptide provides a dual-action model for studying metabolic regulation in peptide research.

Scientific illustration of AOD9604 stimulating lipolysis and inhibiting lipogenesis in fat cells.

Distinction from Full-Length Human Growth Hormone

A significant area of interest for biotech professionals is the structural isolation of functional domains within hGH. While hGH is known for its ability to reduce body fat, its use in research is often complicated by its effects on insulin sensitivity and cellular proliferation.

  • IGF-1 Modulation: Unlike hGH, AOD9604 does not significantly elevate systemic levels of IGF-1. This allows researchers to study lipid metabolism without the confounding variables of systemic growth or organomegaly.
  • Glycemic Control: Full hGH can induce insulin resistance. Preclinical studies on AOD9604 have demonstrated that the fragment does not adversely affect blood glucose levels or insulin sensitivity, making it a unique tool for metabolic syndrome research.

Current Research Applications in Biotechnology

AOD9604 is currently the subject of various preclinical investigations. Its unique profile makes it a candidate for several specialized areas of study.

1. Adipose Tissue Metabolism

In animal models, specifically involving obese mice (ob/ob models), the administration of AOD9604 has been shown to reduce the accumulation of adipose tissue. Researchers use this compound to explore the molecular triggers of fat oxidation and the modulation of metabolic flexibility.

2. Metabolic Syndrome and Obesity Research

The peptide is frequently used in studies focusing on metabolic disorders. Because it targets the beta-3 adrenergic receptor without stimulating the GHR, it provides a specialized framework for observing how concentrated lipolytic activity impacts overall metabolic health in laboratory subjects.

3. Cartilage Regeneration and Osteoarthritis

Emerging research has expanded the scope of AOD9604 beyond metabolic applications. Recent investigations have explored the peptide's potential in the repair of hyaline cartilage. When combined with other compounds or used in isolation, AOD9604 is being studied for its ability to stimulate the differentiation of mesenchymal stem cells into chondrocytes (cartilage cells). This research is of particular interest to biotech professionals focusing on orthopedic applications and degenerative joint conditions.

Biomedical model of knee joint cartilage repair studied in AOD9604 regenerative research.

The Critical Role of High Purity for Laboratory Results

In the field of biotechnology, the integrity of experimental data is directly proportional to the purity of the research material. Utilizing low-grade or unverified peptides can lead to catastrophic failures in experimental design, including off-target effects, toxicity, or inconsistent data points.

Quantitative Analysis: HPLC and Mass Spectrometry

For AOD9604 to produce reliable data, it must undergo rigorous testing. High-Performance Liquid Chromatography (HPLC) is used to determine the purity of the peptide, ensuring it is free from truncated sequences or residual solvents. Mass Spectrometry (MS) is utilized to confirm the exact molecular weight and identity of the fragment. Researchers are encouraged to review COA-s (Certificates of Analysis) before initiating any study.

Consistency in Longitudinal Studies

When conducting long-term research, consistency between batches is essential. High-purity, laboratory-grade AOD9604 ensures that the metabolic response observed in "Trial A" remains consistent in "Trial B." Contaminants in lower-purity samples may trigger inflammatory responses or activate unintended signaling pathways, thereby invalidating the research findings.

Analytical testing of AOD9604 peptide purity using HPLC equipment for biotech research.

Reconstitution and Storage Protocols

Proper handling of AOD9604 is necessary to maintain its molecular stability and biological activity. Peptides are inherently fragile and subject to degradation through heat, light, and mechanical stress.

Reconstitution Procedures

  • Solvent Selection: Lyophilized AOD9604 should be reconstituted using sterile bacteriostatic water or sterile saline, depending on the requirements of the specific research protocol.
  • Technique: The solvent should be introduced to the vial slowly, allowing it to run down the side of the glass. The vial should be gently swirled; vigorous shaking must be avoided as it can cause denaturing of the peptide structure.

Optimal Storage Conditions

  • Lyophilized State: The powder form should be stored at -20°C for long-term stability. It can remain stable at refrigerated temperatures (2-8°C) for shorter durations.
  • Reconstituted State: Once in solution, AOD9604 is significantly more volatile. It must be stored at 2-8°C and used within a short timeframe (typically 7–14 days) to prevent degradation and loss of potency.

Conclusion for Researchers

The study of AOD9604 offers profound insights into the mechanics of lipid metabolism and the potential for targeted tissue regeneration. By isolating the lipolytic fragment of hGH, researchers can explore metabolic pathways with a degree of specificity that full-sequence hormones cannot provide. To ensure the validity of these scientific inquiries, the use of high-purity AOD9604 is non-negotiable.

Disclaimers

FOR RESEARCH USE ONLY
The material described in this article is intended solely for laboratory research purposes. It is not for human consumption, nor is it intended for diagnostic or therapeutic use in humans or animals.

NOT FOR HUMAN USE
AOD9604 has not been approved by the FDA for the treatment of any medical condition. Any mention of biological effects refers to observations made in preclinical animal models or in vitro cellular studies.

LEGAL COMPLIANCE
Researchers are responsible for ensuring that their use of AOD9604 complies with all local, state, and federal regulations regarding the handling and use of experimental compounds in a laboratory setting. Biobulk Peptides provides materials for research purposes only.

All orders are processed and shipped within 24 hours of payment confirmation, excluding weekends and holidays.

For further information on available materials, please visit the products page.